Avadel Pharmaceuticals Announces FDA Acceptance of New Drug Application for FT218 in Adults with Narcolepsy for the Treatment of Excessive Daytime Sleepiness and Cataplexy
Study Results- Perceived Challenges in Pediatric Narcolepsy: A Survey of Parents, Youth, and Sleep Physicians
